| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.004 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |